Reduction in lesions from Lmax: a new concept for assessing efficacy of field-directed therapy for actinic keratosis. Results with imiquimod 3.75%. (Q44449250)
Jump to navigation
Jump to search
scientific article published in January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduction in lesions from Lmax: a new concept for assessing efficacy of field-directed therapy for actinic keratosis. Results with imiquimod 3.75%. |
scientific article published in January 2014 |
Statements
Reduction in lesions from Lmax: a new concept for assessing efficacy of field-directed therapy for actinic keratosis. Results with imiquimod 3.75% (English)
Eggert Stockfleth
Girish Gupta
Rada Dakovic